Premium Only Content

Are New Alzheimer’s Drugs All They Promise To Be?
Researchers question the impact of amyloid immunotherapy on Alzheimer’s, highlighting the small benefits versus significant risks and costs.
Despite regulatory approval by the FDA, other bodies like the EMA express reservations, reflecting broader concerns about these treatments’ real-world efficacy.
Alzheimer’s Immunotherapy Challenges
Cambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impact of Alzheimer’s disease.
Writing in the journal Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the team from Cambridge Public Health argues that substantial challenges including the risk-benefit ratio, limited eligibility, and high cost of the roll-out will limit any benefits of these treatments.
-
LIVE
The Jimmy Dore Show
3 hours agoHolocaust Museum DELETES “Never Again” Post! Rand Paul Calls JD Vance Despicable! w/ Anthony Aguilar
8,246 watching -
1:47:36
Glenn Greenwald
3 hours agoJD Vance and Rand Paul Clash on Due Process: War on Terror Echoes; Has the U.S. Given Up on Confronting China? Ben Shapiro's Latest Falsehoods About Israel | SYSTEM UPDATE #510
60.8K29 -
LIVE
Nerdrotic
12 hours ago $2.49 earnedNerdrotic Nooner 513
360 watching -
LIVE
BigTallRedneck
1 hour agoRANKED FINALS W OMEGA
75 watching -
LIVE
Eternal_Spartan
9 hours ago🟢 Eternal Spartan Plays Final Fantasy 7 Rebirth Ep. 3 | USMC Vet | Join the Best Chat on Rumble
38 watching -
LIVE
megimu32
1 hour agoOTS: Ace Ventura & The Death of 90s Comedy
110 watching -
LIVE
We Like Shooting
14 hours agoDouble Tap 426 (Gun Podcast)
81 watching -
LIVE
Meisters of Madness
4 hours agoWuchang Returns with Madness & Ranked Finals
29 watching -
LIVE
Illyes Jr Gaming
1 hour agoBlack Ops 6 Action Reppin @Mystivis
56 watching -
LIVE
a12cat34dog
1 hour agoCRAZY NEW HORROR GAME :: Cronos: The New Dawn :: SPOOKY SEASON CAME EARLY {18+}
78 watching